Objective: The aim of this study was to investigate the anti-obesity effects of the polyphenol fisetin in 3T3-L1 preadipocytes and C57BL/6 female mice that were fed a high-fat diet (HFD).
Fisetin (3,7,3',4 '-tetrahydroxyflavone) is a polyphenol that is abundant in plants, fruits, and vegetables and exhibits multiple biological activities, such as inhibition of prostate cancer growth [13] , prevention of rheumatoid arthritis [14] , and protection against osteoporosis [15] .
Furthermore, fisetin promotes ERK-dependent long-term potentiation in rat hippocampal slices and enhances memory in mice [16] . Fisetin is also known to act via the activation of the Nrf2 pathway [17] , which is the major regulator of cytoprotective responses to oxidative and electrophilic stress. Recently, it has been reported that fisetin regulates obesity by targeting mammalian target of rapamycin complex 1 signaling, which is a central mediator of lipid biosynthesis [18] .
The present study was designed to evaluate the in vitro and in vivo anti-obesity effects of fisetin in 3T3-L1 adipocytes and HFD-treated mice. Our results indicated that fisetin attenuated adipogenesis in 3T3-L1 cells by inhibiting the expression of PPAR mRNA. Cell culture: Mouse preadipocyte 3T3-L1 cells were obtained from the RIKEN Cell Bank (Tsukuba, Japan). Cells were maintained in a 55-cm 2 dish in DMEM, which was supplemented with 10% fetal bovine serum, 50 units/mL penicillin, and 50 g/mL streptomycin, in a humidified atmosphere of 5% CO 2 in air at 37 °C. After reaching 70% confluence, the cells were detached by treatment with 0.05% trypsin, replated in either 6-well plates (area of each well, 9.4 cm 2 ) or 12-well plates (area of each well, 3.8 cm 2 ) at a density of 2 × 10 4 cells/cm 2 , and grown in DMEM, which was supplemented with 10% fetal bovine serum, 50 units/mL penicillin, and 50 g/mL streptomycin. After confluence, the cells were cultured for 2 days in the presence of various concentrations of fisetin, and continuously cultured for 2 days with 0.25 M of dexamethasone (Sigma-Aldrich K.K.), 0.2 mM 3-iso-butyl-1-methylxanthine (Sigma-Aldrich K.K.), and 10 g/mL insulin (Wako Pure Chemical Industries, Ltd., Osaka, Japan)(DMI induction). The cells were then cultured in medium containing 5 g/mL of insulin.
MATERIALS AND METHODS:

Materials
Animal models: Female 4-week-old C57BL/6J mice were obtained from CLEA Japan, Inc. First, an overview scan of the whole mouse was conducted to allow for the selection of the regions of interest for the different scans. To quantify the visceral and subcutaneous fat depots the area between the proximal end of lumbar vertebra L3 and the distal end of L5 was scanned.
For the liver fat quantification the areas that include liver and spleen (between the cranial part of the diaphragm and the lumbar vertebra L3) and adipose tissue (narrow area in the region of the lumbosacral joint) were scanned. Abdominal muscle was used as a discriminant between the visceral and subcutaneous fat depots.
Sample preparation and procedures:
Eight weeks after supplementation with the experimental diets, the mice were sacrificed. Blood samples were collected from the heart and centrifuged at 1,000 × g for 10 min, and serum triglyceride (TG), total cholesterol, asparatate aminotransferase (AST), and alanine aminotransferase (ALT) levels were measured by BML, Inc. (Tokyo, Japan).
The liver and kidney were excised and fixed in a 10% neutral-buffered formalin solution and processed for histology. The liver and kidney were snap-frozen with Optimal Cutting
Temperature (OCT) compound in liquid nitrogen and stored at -80 °C.
Histological analysis: Fixed tissues were embedded in paraffin, sliced into 4-µm-thick sections and stained with hematoxylin and eosin. The pathological changes were assessed and photographed with the All-in-One Fluorescence Microscope system (BZ-8100 and BZ-Analyzer, Keyence Corporation, Osaka, Japan).
Oil-red O staining: Cells were cultured in medium containing fisetin (0, 25, 50, or 75 M) for 2 days. Frozen liver sections and cells were fixed with 4% paraformaldehyde for 1 h, and then stained with 3 mg/mL Oil-red O (in 60% isopropanol) for 10 min. After washing twice with 60% isopropanol, images were collected on the All-in-One Fluorescence Microscope system.
In addition, the dye was eluted for 10 min with 100% isopropanol. The concentration of the eluted dye was determined from measurements of absorbance (Optical Density, 420 nm).
Glycerol-3-phosphate dehydrogenase (GPDH) activity: GPDH activity was measured with a
GPDH Activity Assay Kit (Takara Bio, Inc., Tokyo, Japan) according to the manufacturer's instructions. One unit was defined as the amount of enzyme that was required for the consumption of 1 μmol of nicotinamide adenine dinucleotide in 1 min at 30 °C. Each assay was conducted in duplicate.
Real-time polymerase-chain-reaction (PCR):
The mRNA levels of expression of PPARγ, adipocyte protein 2 (aP2), and perilipin in 3T3-L1 cells were examined by real-time PCR. The RNeasy Mini Kit (Qiagen K.K., Tokyo, Japan) was used to extract RNA from the cells that had 
Statistical Analysis:
The data are expressed as mean ± standard deviation (SD). The statistical analysis was performed with Student's t-tests to compare the group means with and without fisetin administration. Two-tailed P-values less than 0.05 were considered statistically significant.
RESULTS:
Effects of fisetin on the adipogenetic differentiation of 3T3-L1 preadipocytes: During the differentiation of 3T3-L1 cells, the cells were treated with fisetin at 25 to 75 M, and intracellular oil droplets were stained with Oil-red O and quantified. Fisetin at 50 M and 75
M significantly suppressed lipid accumulation, and 75 M of fisetininhibited it to  compared to dimethyl sulfoxide (DMSO)-treated control cells (Figs. 1A and 1B) . Furthermore, to examine the suppressive effects of fisetin on differentiation, GPDH activity was measured in 3T3-L1 cells that were treated with fisetin (Fig. 1C) . GPDH activity was completely inhibited by 75 M of fisetin. 
Effects of fisetin on HFD-induced obesity:
We examined the effects of fisetin on body weight in C57BL/6 female mice that were fed a control diet or HFD for 8 weeks. Fisetin (20 mg/kg body weight) was intraperitoneally injected into the mice of each group twice per week. Twenty mg/kg body weight of fisetin did not affect the body weights of normal diet (ND) mice, but significantly increased the body weights of HFD-treated mice (Fig. 3A) . Figure 3B shows typical CT images that were obtained with the LA Theta LCT-100 from the abdomen for the detection of fat tissue. Furthermore, the amounts of body fat (Fig. 3C) , abdominal adipose tissue (Fig. 3D) , subcutaneous adipose tissue (Fig. 3E) , and muscle ( Next, we monitored the levels of TG (Fig. 4A ), total cholesterol (Fig. 4B) , AST (Fig. 4C) , and ALT (Fig. 4D) in the blood samples at the end of the 8 weeks of the HFD. Fisetin did not improve the obesity-related blood biochemical parameters in the HFD-treated obesity group.
As shown in Figure 5 , the HFD-treated obese mice had fatty livers (Oil-red O stain), but fisetin did not suppress the fatty livers in the HFD-treated obese mice. Fisetin did not affect the kidneys of ND and HFD-treated obese mice. 
DISCUSSION:
In this study, we attempted to clarify the potential effects of the polyphenol fisetin on obesity, and found that fisetin attenuated adipocyte differentiation (intracellular lipid accumulation and GPDH activity) through the inhibition of the expression of PPARγ mRNA during the differentiation of 3T3-L1 preadipocytes. Furthermore, the injection of fisetin at a dose of 20 mg/kg body weight into HFD-treated obese mice for 8 weeks increased the body weight, but it did not show anti-obesity effects on HFD-induced obesity. The effect of fisetin on weight gain in mice fed a HFD is interesting, although the underlying mechanism is unclear.
C57BL/6 male mice have been used to study HFD-induced obesity [19] [20] [21] [22] . Recently, gender differences in weight gain have been studied in angiotensin receptor- [23] , Nur77- [24] , and lecithin cholesterol acyltransferase-(25) knockout mice with HFD-induced obesity. We used C57BL/6 female mice in this study because we attempted to investigate the effects of fisetin Recently, it was reported that daily fisetin supplementation displayed hypocholesterolemic effects in HFD Sprague-Dawley rats [26] . Future studies on high-dose fisetin in HFD-treated obese mice may aid the prevention of obesity. We also hypothesized from our results that fisetin may decompose in the body. Fisetin may be used as an effective remedy in the treatment of the symptoms of obesity if we are able to elucidate the mechanisms by which fisetin specifically acts upon PPARγ expression in adipocytes.
CONCLUSIONS:
Our results suggested that the inhibition of PPARγ signaling by fisetin inhbited the adipocyte differentiation of 3T3-L1 preadipocytes. However, fisetin at 20 mg/kg body weight did not affect HFD-induced obesity. These findings provide insights into the development of tools for the prevention and treatment of obesity.
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